This page shows the latest allogenic cell therapies news and features for those working in and with pharma, biotech and healthcare.
Unlike other leaders in next-generation cell therapies, the partners will use allogenic T-cells rather than immune cells taken from and returned to an individual’s body as with many ... their cancer; a significant step towards our goal of making cell
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Cellectis, an expert in allogenic CAR T-cell therapies, signed a strategic collaboration with Servier to cover Cellectic's lead product UCART-19 targeted at leukaemia and lymphomas. ... The FDA Complete Response Letter relating to an advanced renal cell
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...